Chemotherapy mist for cancer spread in the belly
Part of Cancer clinical trials.
This trial tests a new way to give chemotherapy directly into the belly as a fine mist (called PIPAC) for people whose cancer has spread there. The goal is to see if it’s safe and helps shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer (adenocarcinoma) must have spread to the lining of your belly (called peritoneum) from the stomach, colon, appendix, or ovary.
- You should be between 18 and 75 years old.
- You must be well enough to do daily activities (not needing to rest more than half the day).
- Your liver, kidney, and blood counts must be within a safe range (your doctor will check this).
- You cannot have a bowel blockage, a serious belly infection, or other unmanaged health problems.
- You cannot be pregnant, breastfeeding, or currently in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give chemotherapy – as a fine mist sprayed directly into the belly during a short laparoscopy (keyhole surgery). It is for people whose stomach, pancreas, or colon cancer has spread to the lining of the belly, and who haven't had much chemotherapy before.
This trial tests a specialized chemotherapy delivery method called PIPAC—where chemotherapy is sprayed directly into the abdomen under pressure—for patients with gastric cancer that has spread to the abdominal lining. The goal is to deliver stronger doses of chemotherapy directly to where the cancer is, potentially helping patients who aren't candidates for major surgery.
This trial tests a new way to deliver chemotherapy directly into the abdomen using a spray (called PIPAC) in people with stomach cancer that has spread to the lining of the belly. The aim is to see if it can help control the cancer with fewer side effects.
This trial tests a treatment called PIPAC, where chemotherapy is sprayed as a mist into the abdomen during a minimally invasive surgery. It is for people whose pancreatic cancer has spread to the lining of the belly, and aims to see if this approach is safe and helpful.
This trial tests a new way to give chemotherapy by spraying it into the belly during a minimally invasive surgery. It is for people whose colon or rectal cancer has spread inside the belly (peritoneal metastasis) but not to other organs.
This trial tests a new way to deliver chemotherapy directly into the abdomen (called PIPAC) for people with cancer spread to the lining of the belly. It uses the drug mitomycin and is for patients who cannot have standard surgery or heated chemotherapy.
Hear when a new Peritoneal Carcinoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.